HOXB13 and gastric cancer: Notably, FTO’s activity is linked with HOXB13 expression through the removal of the m6A modification, with heightened FTO expression along with increased HOXB13 expression being present in the progression of endometrial and gastric cancer [30, 31], yet no link has been described in PCa.